altText copyrightStatement

Ruiyao Wang

Senior Associate Professor

Calculated based on number of publications stored in Pure and citations from Scopus
1996 …2024

Research activity per year

Personal profile

Personal profile

Dr. Ruiyao Wangs research area is on medicinal chemistry based on crystal engineering and coordination chemistry, which aims to develop new medicines underpinned by supramolecular chemistry, coordination and/or organometallic chemistry and crystal engineering, such as pharmaceutical polymorphism, pharmaceutical co-crystallization, as well as Pt(IV) complex-based prodrugs. Currently, Dr. Wangs research focuses on the development of 1) novel pharmaceutical cocrystals; 2) novel drug-drug pharmaceutical cocrystals for antitumor drugs; 3) targeted Pt(IV) complex-based prodrugs for antitumor applications; and 4) drug formulation. Dr. Wang joined XJTLU in December, 2012 as an Associate Professor. Prior to XJTLU, Dr. Wang worked as the X-ray Lab manager and departmental X-ray crytsallographer at the Chemistry Department of Queens University, Canada (2002-2012), post-doctorial fellow and research associate at the University of Arizona, US and Queens University (1998-2001). He received his PhD from Peking University in 1997, and MS from Changchun Institute of Applied Chemistry, CAS. Dr. Wang has published over 150 research papers (https://scholar.google.com/citations?hl=zh-CNamp;user=dNtV9HMAAAAJ), and 3 book chapters. He also owns one US/Canada patent and one China patent.

Research interests

Dr. Ruiyao Wangs research area is on medicinal chemistry based on crystal engineering and coordination chemistry, which aims to develop new medicines underpinned by supramolecular chemistry, coordination and/or organometallic chemistry and crystal engineering, such as pharmaceutical polymorphism, pharmaceutical co-crystallization, as well as Pt(IV) complex-based prodrugs. Currently, Dr. Wangs research focuses on the development of 1) novel pharmaceutical cocrystals; 2) novel drug-drug pharmaceutical cocrystals for antitumor drugs; 3) targeted Pt(IV) complex-based prodrugs for antitumor applications; and 4) drug formulation.

Experience

Senior Associate Professor, Chemistry Department, Xian Jiaotong-Liverpool University, Suzhou, China-2022 to present

Associate Professor, Chemistry Department, Xian Jiaotong-Liverpool University, Suzhou, China-2012 to 2022

X-ray Lab Manager/Departmental Crystallographer, Chemistry Department, Queen’s University, Canada - 2002 to 2012

Research Associate, Chemistry Department, Queen’s University, Canada - 2000 to 2002

Postdoctoral Fellow, Chemistry Department, University of Arizona, USA - 1998 to 2000

Associate Professor, Chemistry Department, Xi’an Jiaotong-Liverpool University, China - 2012 to Present

Teaching Assistant/Lecturer/Associate Head of the Department, Chemistry Department, College of Art and Sciences, Hebei Agricultural University, China - 1983 to 1998

Awards and honours

1995 Guanghua Scholarship for PhD Students, Peking Uiniversity, China

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 7 - Affordable and Clean Energy

Education/Academic qualification

Ph.D. , Beijing University, - 1997

MSc , Changchun Institute of Applied Chemistry, CAS, - 1990

Person Types

  • Staff

Fingerprint

Dive into the research topics where Ruiyao Wang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or